• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket

    12/28/22 7:54:47 AM ET
    $BITF
    $BLNK
    $CORZ
    $ELYS
    Finance: Consumer Services
    Finance
    Industrial Specialties
    Consumer Discretionary
    Get the next $BITF alert in real time by email

    Gainers

    • Minerva Surgical, Inc. (NASDAQ:UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) rose 74.9% to $1.29 in pre-market trading after Gilead Sciences announced plans to acquire all remaining rights to the company's Immunotherapy GS-1811, an anti-CCR8 antibody, for $67 million.
    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares rose 40.8% to $5.52 in pre-market trading after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) rose 15.2% to $7.83 in pre-market trading after dropping 15% on Tuesday. Nano X Imaging, last month, posted a Q3 loss of $0.15 per share.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 14% to $0.1653 in pre-market trading after gaining around 9% on Tuesday.
    • Blink Charging Co. (NASDAQ:BLNK) rose 13.3% to $11.58 in pre-market trading. Blink Charging recently signed an agreement with Bosch as an official EV charging solutions provider for GM dealerships.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) rose 11.8% to $0.76 in pre-market trading after dipping 36% on Tuesday. Lion Group recently posted a H1 loss of $0.52 per share.
    • Pagaya Technologies Ltd.. (NASDAQ:PGY) rose 10.7% to $1.14 in pre-market trading after climbing 23% on Tuesday.
    • SPI Energy Co., Ltd. (NASDAQ:SPI) shares rose 10.4% to $0.85 in pre-market trading after declining 6% on Tuesday.
    • Bitfarms Ltd. (NASDAQ:BITF) rose 7.9% to $0.410 in pre-market trading. Bitfarms completed the sale of its de la Pointe property, receiving $3.6 million in net proceeds.
    • SmileDirectClub, Inc. (NASDAQ:SDC) rose 7.4% to $0.3381 in pre-market trading after dropping 10% on Tuesday.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) rose 6.3% to $0.2950 in pre-market trading. Grove announced refinancing of existing debt, extending maturity with principal payments beginning in 2025.


    Losers

    • Minerva Surgical (NASDAQ:LJAQ) shares fell 31.3% to $13.06 in pre-market trading after surging around 99% on Tuesday. Shareholders of the company have approved its combination with Moolec Science, according to Marketwatch.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) fell 26.4% to $0.2725 in pre-market trading after jumping around 40% on Tuesday.
    • Elys Game Technology, Corp. (NASDAQ:ELYS) fell 26% to $0.2739 in pre-market trading. Elys Game Technology shares jumped around 112% on Tuesday after the company and Cloakbook were granted a license to commence sportsbook operations in Washington, D.C.
    • Quotient Limited (NASDAQ:QTNT) fell 21.7% to $0.2898 in pre-market trading after jumping around 95% on Tuesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market.
    • Gemini Therapeutics, Inc. (NASDAQ:GMTX) fell 13.3% to $1.17 in pre-market trading after declining around 13% on Tuesday. Disc Medicine announced it received Orphan Drug Designation for bitopertin for the treatment of erythropoietic protoporphyria.
    • Core Scientific, Inc. (NASDAQ:CORZ) shares fell 13% to $0.0784 in pre-market trading. On December 22, 2022, Core Scientific received written notice from the Nasdaq notifying that the company’s common stock will be delisted from Nasdaq.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 10.7% to $0.48 in pre-market trading after gaining over 7% on Tuesday.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 8.4% to $1.75 in pre-market trading after gaining over 10% on Tuesday.
    • Companhia Siderúrgica Nacional (NYSE:SID) fell 9.7% to $2.50 in pre-market trading.
    • Expion360 Inc. (NASDAQ:XPON) fell 9.1% to $1.91 in pre-market trading after dropping over 10% on Tuesday. Expion360 recently announced it has been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer to be branded and sold by a top U.S. sports utility vehicle manufacturer.
    • Venus Concept Inc. (NASDAQ:VERO) shares fell 8.8% to $0.26 in pre-market trading. Venus Concept recently announced it received a 510(k) clearance from the FDA to market its AI.ME next generation robotic technology for fractional skin resurfacing.
    • Oatly Group AB (NASDAQ:OTLY) shares fell 7.1% to $1.31 in pre-market trading. Oatley, last month, reported worse-than-expected Q3 EPS and sales results..
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 5.6% to $0.3399 in pre-market trading after surging over 35% on Tuesday. Shohaib Kassam Sumar disclosed a 5.1% active stake in Neptune Wellness Solutions.
    • Tesla, Inc. (NASDAQ:TSLA) fell 3.6% to $105.21 in pre-market trading. Shares of Tesla dropped around 11.4% on Tuesday after a Reuters report indicated the company was intending to run a reduced production schedule in January at its Shanghai plant causing concerns over demand.

    Read More: Investor Fear Increases After Nasdaq Drops Over 1%

    Get the next $BITF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BITF
    $BLNK
    $CORZ
    $ELYS

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    9/26/2025$345.00 → $435.00Buy
    Deutsche Bank
    Tesla Inc.
    $TSLA
    9/23/2025$375.00 → $450.00Outperform
    Mizuho
    Tesla Inc.
    $TSLA
    9/22/2025$400.00 → $500.00Overweight
    Piper Sandler
    Tesla Inc.
    $TSLA
    9/19/2025$548.00Neutral → Outperform
    Robert W. Baird
    Tesla Inc.
    $TSLA
    9/18/2025$300.00 → $395.00Neutral
    Goldman
    Core Scientific Inc.
    $CORZ
    9/15/2025Buy
    Compass Point
    Bitfarms Ltd.
    $BITF
    9/15/2025Buy
    Compass Point
    KALA BIO Inc.
    $KALA
    9/8/2025$30.00Outperform
    Mizuho
    More analyst ratings

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank reiterated coverage on Tesla with a new price target

    Deutsche Bank reiterated coverage of Tesla with a rating of Buy and set a new price target of $435.00 from $345.00 previously

    9/26/25 7:50:10 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Mizuho reiterated coverage on Tesla with a new price target

    Mizuho reiterated coverage of Tesla with a rating of Outperform and set a new price target of $450.00 from $375.00 previously

    9/23/25 7:51:42 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Piper Sandler reiterated coverage on Tesla with a new price target

    Piper Sandler reiterated coverage of Tesla with a rating of Overweight and set a new price target of $500.00 from $400.00 previously

    9/22/25 8:58:15 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hubject Teams with Blink Charging to Further Expand Intercharge Network Across North America

    Bowie, Md., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co., (NASDAQ:BLNK)("Blink" or the "Company"), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services today announced a strategic collaboration agreement with Hubject, the global leader in eMobility interoperable charging solutions. This collaboration will integrate Blink as a Charge Point Operator (CPO) into Hubject's intercharge eRoaming platform, significantly expanding charging options for eMSPs and their customers across the United States, Canada, and Mexico. The agreement expected to further strengthen Hubject's North American market position by adding Blink's comprehensive chargin

    9/22/25 8:30:00 AM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    Grove Launches New Open-Source Approach to Sustainable AI Measurement

    Company is a first mover through new commitments, enabling industry to mindfully adopt AI through an expanded measurement partnership with Gravity Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or "the Company"), the world's first plastic neutral retailer, leading sustainable consumer products company, Certified B Corporation, and Public Benefit Corporation, today announced a new set of commitments to measure, mitigate, and report the environmental impact of artificial intelligence (AI) adoption in partnership with Gravity, the Company's existing carbon accounting platform. Grove wants to prove AI can be a force for good without ignoring its environmental cost by becoming the fir

    9/22/25 8:00:00 AM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging

    Collaboration spans workers' compensation, nursing homes, and outpatient clinics PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced a collaboration between its U.S. subsidiary Nanox Impact Inc. and Monarch Medical Management and Billing LLC ("Monarch"), an experienced healthcare management organization with established relationships across industry sectors, to deploy Nanox's advanced imaging solutions across multiple healthcare segments including workers' compensation, nursing home facilities, and outpatient clinics. As part of the collaboration, Nan

    9/18/25 8:00:07 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $BITF
    $BLNK
    $CORZ
    $ELYS
    SEC Filings

    View All

    SEC Form 6-K filed by Lion Group Holding Ltd.

    6-K - Lion Group Holding Ltd (0001806524) (Filer)

    9/26/25 4:01:02 PM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    SEC Form DEFA14A filed by Tesla Inc.

    DEFA14A - Tesla, Inc. (0001318605) (Filer)

    9/25/25 5:00:55 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form DEFA14A filed by Tesla Inc.

    DEFA14A - Tesla, Inc. (0001318605) (Filer)

    9/24/25 5:00:51 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Director Levine Jack bought $21,525 worth of shares (21,000 units at $1.02) (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    9/8/25 2:49:32 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    Chief Financial Officer Bercovich Michael bought $6,144 worth of shares (6,000 units at $1.02), increasing direct ownership by 5% to 123,230 units (SEC Form 4)

    4 - Blink Charging Co. (0001429764) (Issuer)

    9/5/25 7:23:38 PM ET
    $BLNK
    Industrial Specialties
    Consumer Discretionary

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zeevi Avi acquired 82,703 units of Class A Ordinary Share, increasing direct ownership by 125% to 149,015 units (SEC Form 4)

    4 - Pagaya Technologies Ltd. (0001883085) (Issuer)

    9/25/25 4:15:37 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    Director Murdoch James R sold $25,360,800 worth of shares (60,000 units at $422.68) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/17/25 7:00:22 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Director Petrozzo Dan sold $117,168 worth of Class A Ordinary Share (2,828 units at $41.43), decreasing direct ownership by 3% to 93,450 units (SEC Form 4)

    4 - Pagaya Technologies Ltd. (0001883085) (Issuer)

    9/17/25 4:02:13 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Leadership Updates

    Live Leadership Updates

    View All

    Expion360 Appoints Shawna Bowin as Chief Financial Officer

    Veteran Financial and Accounting Professional to Lead Next Phase of Company Growth REDMOND, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (NASDAQ:XPON) ("Expion360" or the "Company"), an industry leader in lithium-ion battery power storage, today announced the appointment of Shawna Bowin, Controller of Expion360, as Chief Financial Officer of the Company, replacing Brian Schaffner, Chief Executive Officer, who has also been serving as the Company's interim Chief Financial Officer. Ms. Bowin is an accounting professional with over 20 years of progressive experience in accounting and a proven track record serving public and private companies. She joined Expion360 in 2022 as Senio

    9/8/25 4:03:00 PM ET
    $XPON
    Industrial Machinery/Components
    Miscellaneous

    Terra Innovatum Announces Post-Closing Board of Directors and Nominates Former Framatome CEO Katherine Williams as Chair

    Led by former Framatome CEO Katherine Williams as Chair, diversified Board to be comprised of seasoned technology and nuclear industry leaders with public company experience and expertise across the nuclear value chain—from fuel cycle and regulatory licensing to large-scale project execution and commercializationDirectors bring a mix of relevant global leadership experience, investment expertise, and commercial networks as current and former C-Suite executives, Board directors, academics and advisors NEW YORK and AUSTIN, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl ("Terra Innovatum," or the "Company"), a developer of micro-modular nuclear reactors, and GSR III Acquis

    9/4/25 8:00:00 AM ET
    $BLNK
    $CHPT
    $GSRT
    Industrial Specialties
    Consumer Discretionary
    Oil & Gas Production
    Energy

    KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director

    ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that Todd Bazemore has been named President and Chief Executive Officer (CEO) of KALA BIO and appointed to the Board of Directors. Mr. Bazemore has served as KALA's interim CEO since February 2025 and previously served as KALA's President and Chief Operating Officer (COO). "Throughout his tenure, including as interim CEO and President and COO, Todd's leadership has been instrumental in driving KALA's clinical progress and str

    9/2/25 8:00:00 AM ET
    $KALA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by KALA BIO Inc.

    SC 13G - KALA BIO, Inc. (0001479419) (Subject)

    11/14/24 4:49:42 PM ET
    $KALA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Expion360 Inc.

    SC 13G/A - Expion360 Inc. (0001894954) (Subject)

    11/13/24 6:49:41 PM ET
    $XPON
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Pagaya Technologies Ltd.

    SC 13G/A - Pagaya Technologies Ltd. (0001883085) (Subject)

    11/13/24 4:29:40 PM ET
    $PGY
    Finance: Consumer Services
    Finance

    $BITF
    $BLNK
    $CORZ
    $ELYS
    Financials

    Live finance-specific insights

    View All

    Expion360 Reports Second Quarter 2025 Financial and Operational Results

    Q2 2025 Sales Growth of 134% to $3.0 Million Fueled by Strong Demand for New Products and Technologies Records Two of the Most Successful Months of Sales in Company History in Q2 2025 Sixth Consecutive Quarter of Sales Growth REDMOND, Ore., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (NASDAQ:XPON) ("Expion360" or the "Company"), an industry leader in lithium iron phosphate battery power storage, today reported its financial and operational results for the first quarter ended June 30, 2025. Second Quarter 2025 and Subsequent Financial and Operational Highlights Q2 2025 net sales totaled $3.0 million, up 134% from Q2 2024, and up 46% from Q1 2025.First half 2025 net sale

    8/13/25 4:05:00 PM ET
    $XPON
    Industrial Machinery/Components
    Miscellaneous

    Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update

    Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2025 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the second quarter of 2025, compared to $2.7 million in the second quarter of 2024.Grew Nanox.ARC system sales funnel exponentially in the quarter.The Company notified the FD

    8/12/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Bitfarms Reports Second Quarter 2025 Results

    Executing HPC/AI Growth Strategy with Industry-Leading Strategic Partners & Robust Balance Sheet - Revenue of $78 million, up 87% Y/Y -- Gross mining margin of 45%, down from 51% in Q2 2024 - - Master Site Plan for Panther Creek, PA data center campus submitted to Macquarie -- Partnered with data center builder and operator T5 Data Centers to advance HPC/AI development at its Panther Creek campus in Pennsylvania - This news release constitutes a "designated news release" for the purposes of the Company's second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and NE

    8/12/25 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance